Showing results (381-390 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|December 5, 2015
Adverse drug reactions due to drug-drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR methodEmre Yucel, Mesut Sancar, Aylin Yucel, et al.Expert Opinion on Drug Safety|November 17, 2015
The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safetyRyma Ihaddadene, Marc CarrierExpert Opinion on Drug Safety|December 16, 2015
Safety of mTOR inhibitors in adult solid organ transplantationPedro Ventura-Aguiar, Josep Maria Campistol, Fritz DiekmannExpert Opinion on Drug Safety|December 10, 2015
The safety of drug treatments for cervical cancerAlfonso Dueñas-González, Lucely Cetina, Jaime Coronel, et al.Expert Opinion on Drug Safety|November 22, 2017
First experiences with a tool to measure the level of clinical information present in adverse drug reaction reportsIngrid Oosterhuis, Leàn Rolfes, Corine Ekhart, et al.Expert Opinion on Drug Safety|October 31, 2017
Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agentsCarola Rong, Nicole E Carmona, Yena L Lee, et al.Expert Opinion on Drug Safety|September 22, 2017
Cardiovascular effects of methadone and concomitant use of diazepam during methadone maintenance treatment induction: low concentration riskVesna Mijatović, Isidora Samojlik, Stojan Petković, et al.Expert Opinion on Drug Safety|September 14, 2017
Lurasidone: efficacy and safety in the treatment of psychotic and mood disordersMaurizio Pompili, Claudio Verzura, Giada Trovini, et al.Expert Opinion on Drug Safety|March 6, 2018
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPDMaria Gabriella Matera, Luigino Calzetta, Ermanno Puxeddu, et al.Expert Opinion on Drug Safety|January 10, 2018
The role of Iloprost on bone edema and osteonecrosis: Safety and clinical resultsIppokratis Pountos, Peter V GiannoudisPageof 281